Related by context. All words. (Click for frequent words.) 60 Incyte Genomics 59 ZyStor Therapeutics Inc. 59 Ferghana Partners 58 Bayhill Therapeutics 58 WeissComm Partners +#-#-#-# 58 Mintz Levin Represents 57 Hydra Biosciences 57 EdgeWater Research Partners 57 Chromos Molecular Systems 57 ThinkEquity Partners LLC 57 Bellus Health 57 Therapeutic Competitors 57 Files Shelf Registration Statement 57 Kelly Luethje #-#-# 56 Nasdaq SOMX 56 Predix Pharmaceuticals 56 Cellerant Therapeutics 56 Biomarin Pharmaceutical 56 Salmedix 56 Protein Polymer Technologies 56 NASDAQ VRUS 56 Endures Analyst Downgrade 56 Aderis 56 InvestBio 56 Nasdaq HLCS 56 Oxis International 56 CONTACT ICR 56 TolerRx 56 AMEX ISV 55 Nereus Pharmaceuticals 55 ISTO Technologies Inc. 55 Eric Ende 55 Elixir Pharmaceuticals 55 OrbiMed Advisors LLC 55 Raven Biotechnologies 55 analyst Liana Moussatos 55 NASDAQ MOGN 55 Natunola Health 55 NASDAQ SIVB 55 NASDAQ DIGE 55 Agios Pharmaceuticals 55 InKine Pharmaceutical Company 55 NASDAQ GNLB 54 Rinat Neuroscience 54 NASDAQ RNAI 54 Nasdaq IPXL 54 Stelios Papadopoulos 54 Orbimed 54 Immunosyn Corporation 54 Tullis Dickerson 54 Welcomes Analyst Initiation 54 Adventrx Pharmaceuticals 54 VIA Pharmaceuticals 54 CapStone Investments 54 AMEX OPK 54 Tailwind Capital 54 Locus Pharmaceuticals 54 Khandaker Partners 54 Prion Developmental Laboratories 54 Nasdaq THLD 54 Completes Recapitalization 54 Freedom Meditech 54 Xcyte Therapies 54 LifeTech Capital 54 LifeCell Corporation 54 Nasdaq BPUR 54 PDL BioPharma Inc 54 TissueInformatics 54 Dynogen Pharmaceuticals 54 Echelon Biosciences 53 Nasdaq PANC 53 Cooley Godward LLP 53 Arriva Pharmaceuticals 53 Xenon Pharmaceuticals 53 Therapeutic Competitors Companies 53 Ironwood Pharmaceuticals 53 Corixa Corporation 53 Nasdaq ZIOP 53 Taligen Therapeutics 53 Epoch Biosciences 53 Resumes Coverage 53 Xmark Funds 53 Marinus Pharmaceuticals 53 Creditsights 53 Relational Advisors 53 NASDAQ LIPD 53 NASDAQ ERES 53 NASDAQ ADLR 53 Competitor Report 53 Nasdaq VVUS 53 NASDAQ BMRN 53 Nasdaq MERR 53 NASDAQ VRTS 53 PathoGenesis 53 Immunex Corporation 53 Kingsdale Capital Markets 53 QuatRx Pharmaceuticals 53 analyst Hari Sambasivam 53 RDYN 53 Viacell 53 Nasdaq AVNR 53 Toucan Capital 53 Northland Capital Markets 53 Meritage Pharma 53 Inc Therapeutic Competitors 53 NASDAQ PDLI 53 Genetronics Biomedical 53 JSB Partners 53 ZymoGenetics NASDAQ ZGEN 53 Dain Bosworth 53 BioTherapeutics 53 Quinton Cardiology Systems 53 ACLARA BioSciences 53 Zars Pharma 53 Efficas 53 Orbimed Advisors 53 Nasdaq MOGN 53 ConjuGon 53 HBM BioVentures 53 Bioventures 53 AltaCorp Capital 52 NIF Ventures 52 NASDAQ LIFC 52 Lexicon Genetics 52 NASDAQ AFFY 52 NASDAQ VPHM 52 Orchid Biosciences 52 Nasdaq IDIX 52 Nasdaq ANDS 52 Sanarus Medical 52 GeoVera Insurance Group 52 Metaphore Pharmaceuticals 52 Nasdaq ILXO 52 Recom Managed Systems 52 Nasdaq OMRI 52 Alza Corporation 52 Genetic Therapy 52 Adamis Pharmaceuticals 52 Analysts Initiate Coverage 52 Achillion Pharmaceuticals 52 Ascenta Therapeutics 52 Lexicon Pharmaceuticals 52 Bala Cynwyd Pennsylvania 52 Neotropix 52 Nephros Therapeutics 52 Steven Burakoff 52 Therapeutic Competitors companiesandmarkets.com adEgemonye 52 CapStone 52 GendeLLindheim BioCom Partners 52 Fidelity Biosciences 52 Seikagaku 52 Mediphase Venture Partners 52 Gemin X Biotechnologies 52 NASDAQ DVAX 52 Leerink Swan 52 CancerVax Corporation 52 Nastech Pharmaceutical Company 52 Nasdaq RXII 52 DARA Biosciences 52 Devax 52 ThinkPanmure LLC 52 Emphasys Medical 52 Inc SPPI 52 Mpex Pharmaceuticals 52 Webcast Presentations 52 TherOx 52 noninvestment banking 52 Kythera Biopharmaceuticals 52 OTCBB EVSC 52 Virion Systems 52 Announces Postponement 52 Trellis Bioscience 52 NASDAQ NKTR 52 Completes Merger With 52 Nasdaq SPPI 51 Aestus Therapeutics 51 Joe Pantginis 51 NASDAQ NSTR 51 Sunesis Pharmaceuticals 51 Nasdaq CYTR 51 GCA Savvian Advisors 51 Hybridon 51 KERN Partners 51 NASDAQ TRBN 51 NASDAQ CERS 51 Viamet Pharmaceuticals 51 NanoGram Devices 51 HBM Partners 51 Gunderson Dettmer 51 AMEX TTP 51 Deliver Presentation 51 Bearish MACD 51 Sets Quarterly Dividend 51 Amends Agreement 51 Announces Recapitalization 51 Nasdaq DVAX 51 Genome Therapeutics 51 OTCBB FCSC 51 Nasdaq LEXG 51 Reiterates Hold 51 NASDAQ CRGN 51 Shemano Group 51 Prometheus Laboratories 51 InVivo Therapeutics Holdings 51 Celera Genomics Group 51 VIRxSYS Corporation 51 Sharklet Technologies 51 Corp. IART 51 RenaMed 51 Xcyte Therapies Inc. 51 Member CIPF 51 Nina Kjellson 51 Centerview Partners LLC 51 ImmuneRegen BioSciences wholly owned 51 Reiterates Buy Rating 51 Akebia Therapeutics 51 MPM Capital LP 51 InteKrin Therapeutics 51 INDUSTRY KEYWORD BANKING SOURCE 51 Xytis 51 COO Exercises Options 51 Nasdaq SNSS 51 Fletcher Spaght Ventures 51 HC Wainwright 51 OTCBB DORB 51 NASDAQ OMER 51 Helicon Therapeutics 51 Biophan Technologies 51 Rafferty Capital Markets 51 Corvas International 51 Phillip B. Donenberg 51 Finalizes Purchase 51 analyst Jim Birchenough 51 specialty biotherapeutics 51 Synergy Pharmaceuticals 51 Paradigm Genetics 51 Nasdaq CRTX 51 NASDAQ SGMO 51 Genitope Corp. 51 BioMarin Pharmaceuticals 51 Nasdaq AVII 51 NASDAQ ACOR 51 Amex JAV 51 Mersana Therapeutics 51 member CIPF 51 Nasdaq GORX 50 Genstar Capital LLC 50 CAMBRIDGE Mass. Vertex Pharmaceuticals 50 Sigma Tau Pharmaceuticals 50 -organic yerba mate 50 Allon Therapeutics 50 Pathway Diagnostics 50 Theregen 50 Inc.David 50 Anacor Pharmaceuticals 50 Olshan Grundman Frome Rosenzweig 50 Analysts Begin Coverage 50 InvestorRelations +#-#-#-# 50 Copernicus Therapeutics 50 Sagent Pharmaceuticals Inc. 50 Nasdaq ALSE 50 GTCR Golder Rauner 50 SunTrust Capital Markets 50 Medica Venture Partners 50 ParaPRO 50 Genaera Corporation 50 Durect Corporation 50 Nasdaq CADX 50 Cutfield Freeman 50 Neurobiological Technologies Inc. 50 Feltl 50 Aurora Biosciences 50 Conforma Therapeutics 50 TriPoint Global Research 50 Completes Buyout 50 Clarus Securities 50 Advanced Biotechnologies 50 ISIS Pharmaceuticals 50 HaptoGuard 50 NASDAQ TGEN 50 NASDAQ KERX 50 Shareholders Approve Acquisition 50 Leerink Swann LLC 50 NASDAQ TSPT 50 Nasdaq ANDS announced 50 Targeted Genetics Corporation 50 Emisphere Technologies 50 Progenics Pharmaceuticals 50 Medistem Laboratories 50 Confluent Surgical 50 Alesco Financial 50 Prism Pharmaceuticals 50 Nasdaq BSTE 50 Earnings Postmortem 50 Nasdaq ENMD 50 Tracon Pharmaceuticals 50 Bone Biologics 50 ImQuest Pharmaceuticals 50 AVNC 50 OTCBB NEOP 50 NASDAQ CORT 50 Ciphergen Biosystems Inc. 50 AFX Biopharmaceutical 50 Sonenshine Partners 50 Nasdaq BMRN 50 Announce Merger Agreement 50 OTC IPXL today 50 Jim Birchenough 50 China Nuokang Bio 50 Aegerion Pharmaceuticals Inc. 50 ArrowPath 50 HighMark Funds 50 MediVas LLC 50 CE Unterberg 50 Transcept Pharmaceuticals 50 Nasdaq MERR acted 50 OTCBB GOVX 50 Frankfurt XMP 50 CellExSys 50 Gelesis 50 Explore Strategic Alternatives 50 AMEX QSC 50 Enters Oversold Territory 50 analyst Jim Reddoch 50 NASDAQ OGXI 50 RBC Capital Mkts Reiterate 50 analyst Ghansham Panjabi 50 CRESA Partners 50 Nasdaq MAXM SSE MAXM 50 NASDAQ PARD 50 NASDAQ EMIS 50 Kinetic Ventures 50 Inc.Investors 50 SVP Exercises Options 50 Logo SOURCE 50 Prolog Ventures 50 Eyetech Pharmaceuticals 50 PharmaCore 49 Chardan Capital Markets 49 Perseus Soros BioPharmaceutical Fund 49 CenterPoint Ventures 49 Craig Tooman 49 Syndicate Prospectus Department 49 Dianon Systems 49 Stockwire.com OTC 49 Pharmacopeia Drug 49 Nasdaq OLGC 49 Fiduciary Asset Management 49 CEO Exercises Options 49 AVAX Technologies Inc. 49 Cyto Pulse Sciences 49 Frozen Shoulder syndrome 49 Bearish Pressure Building 49 AltaRex 49 Pillsbury Winthrop LLP 49 Inc. NASDAQ IDMI 49 Eric Brielmann 49 Sangamo BioSciences 49 Nasdaq AVNC 49 JMP Group 49 Analysts Downgrade 49 Investigates Buyout 49 Brainstorm Cell Therapeutics 49 Dynogen Pharmaceuticals Inc. 49 Nasdaq NPSP 49 Abbott Spine 49 Therion Biologics 49 BNY Capital Markets 49 Shareholders Approve Merger Agreement 49 TSX CTI 49 BioLife Solutions 49 Holiday Fenoglio Fowler 49 FinPro 49 CPA CFP ® 49 Fujisawa Healthcare Inc. 49 Nasdaq MGRM 49 Explores Strategic Alternatives 49 Dynavax Technologies 49 Nasdaq AUXL 49 AMEX DDD 49 Maxim Pharmaceuticals 49 Maintains Neutral Rating 49 AMEX RGN 49 Completes Acquisitions 49 Gunderson Dettmer Stough Villeneuve 49 TPG Ventures 49 Inc.Michael 49 Mastodon Ventures 49 Aspreva Pharmaceuticals 49 GenSci 49 Akesis Pharmaceuticals 49 Verus Pharmaceuticals 49 hiSoft Technology International 49 Nasdaq PARD 49 LLP Investigates 49 SAIL Venture Partners 49 Nasdaq DIGE News 49 Paramount BioSciences 49 Fibrocell Science Inc. 49 OTCBB GNTA 49 MultiCell Technologies 49 SWOT Analysis Aarkstore Enterprise 49 Inc. Nasdaq COLY 49 Morgan Joseph TriArtisan 49 Florian Lahnstein 49 Ortho McNeil Pharmaceuticals 49 CoLucid Pharmaceuticals 49 NASDAQ BDSI 49 analyst Ken Trbovich 49 Sangamo BioSciences Inc. 49 Trend Macrolytics LLC 49 Stressgen Biotechnologies 49 itssubsidiaries 49 Rigel Pharmaceuticals 49 Post Earnings Checkup 49 Viriathus Capital 49 OTCBB CHKT 49 PLx Pharma 49 Gryphon Partners 49 Wildeboer Dellelce LLP 49 Exploring Strategic Alternatives 49 Emergent Technologies 49 Kalpesh Kapadia 49 Federated Kaufmann Fund 49 OTCBB IMNR 49 WFC.N 49 Tapestry Pharmaceuticals Inc. 49 BBAC LLC 49 Nasdaq INCY announced 49 Nasdaq LXRX 49 AVEO Pharmaceuticals 49 Nasdaq BDSI 49 NASDAQ PSTI 49 IIROC Halt 49 Files Preliminary Prospectus 49 SSR Realty Advisors 49 Hycor Biomedical 49 Advancis Pharmaceutical Corporation 49 Zelos Therapeutics 49 ProChon Biotech Ltd. 49 BancBoston Ventures 49 Nasdaq SGMO 49 Vitro Technologies 49 Announces Presentation 49 Reiterate Buy rating 49 Array Biopharma 49 ViRexx Medical 49 CFO Exercises Options 49 Sangamo Biosciences 49 Cerexa Inc. 49 Dara BioSciences 49 NYSE Amex OPK 49 Inc. http:/www.endocare.com 49 CIVC Partners 49 Successfully Completes Tender Offer 49 Trius Therapeutics 49 Alnylam Pharmaceuticals Inc 49 Xanthus Pharmaceuticals Inc. 49 Nasdaq GENR 49 CytomX Therapeutics 49 OTCBB CTIX 49 Potentia Pharmaceuticals 49 Inc.Investor Contact 49 Northwater Capital 49 Cormark Securities 49 Ore Pharmaceuticals 49 PANC 49 Amorcyte 49 CRESA Partners represented 49 eGene Inc. 49 Alliant Pharmaceuticals 49 NASDAQ. 49 TNOX 49 SGMO 48 CorMedix NYSE Amex 48 Inc. NASDAQ ORXE 48 Kenneth Zaslow 48 Director Exercises Options 48 Reiterates Neutral Rating 48 Neurome 48 MidCap Financial 48 OTCBB NRGX 48 Announces Repurchase 48 Abernathy MacGregor Group 48 Shares Plunged What 48 OncoGenex Technologies 48 NYSE CNGL 48 Lowenstein Sandler PC 48 Secures Financing 48 Jason Kantor 48 Stem Cell Innovations 48 Reiterates Hold Rating 48 VanthedgePoint Group 48 CeNeRx BioPharma 48 Wolf Haldenstein Investigating 48 ANGN 48 Hepregen 48 Horst Hueniken 48 Navdeep Jaikaria 48 Dusa Pharmaceuticals 48 Insmed Incorporated NASDAQ INSM 48 Digene Corporation 48 NASDAQ SPEX 48 Announce Licensing Agreement 48 Apricus Bio Nasdaq APRI 48 Marret Asset Management 48 NASDAQ PCYC 48 DOV Pharmaceutical Inc. 48 Eastdil Realty 48 Purchases Stake 48 RALEIGH NC Salix Pharmaceuticals 48 NASDAQ ANDS 48 Amir Nashat 48 VP Exercises Options 48 Trubion Pharmaceuticals Inc. 48 OTCBB ADXS 48 Nasdaq NUVO 48 S. Scibetta 48 NASDAQ BJGP 48 Piper Jaffrey 48 IOMAI 48 Reiterates Outperform 48 XOMA Ltd. 48 Unterberg Towbin 48 Tianyin Pharmaceutical 48 Memgen 48 CalEast Industrial Investors 48 Nasdaq VRTX today 48 Morphosys AG 48 Neuromed Pharmaceuticals 48 Signs Merger Agreement 48 Nasdaq LNDC 48 Jefferies Broadview 48 Doug Sipkin 48 Nasdaq BIIB 48 Houlihan Lokey Howard 48 Lockton Insurance Brokers 48 Sagent Advisors 48 High Throughput Genomics 48 Nasdaq ONXX 48 Sandfire Securities 48 Integral Wealth 48 ProQuest Investments 48 USBX Advisory Services 48 Upcoming Conferences 48 Dawntreader Ventures 48 Emerging Markets Consulting 48 Nasdaq AVII today 48 NASDAQ REGN 48 Celera CRA 48 firm LanczGlobal 48 Sapphire Therapeutics 48 EVC Group 48 NASDAQ ALTU 48 Altus Pharmaceuticals 48 Trius Therapeutics Inc. 48 Rule Breakers pick 48 NASDAQ SLXP 48 Inc. NASDAQ OCLS 48 Westrock Advisors 48 Nasdaq RDEA 48 Nasdaq AMAG 48 Ellenoff Grossman & 48 Nasdaq ADLR 48 Upside Looming 48 Trubion Pharmaceuticals 48 Gerard Klauer Mattison 48 Joanne Wuensch 48 Stockholders Approve Merger 48 IR BioSciences Holdings 48 NASDAQ ISIS 48 Ceragenix Pharmaceuticals 48 Fleishman Hillard +#-#-#-# 48 OTCBB MCET 48 Aveo Pharmaceuticals 48 Prudential Bache Securities 48 Grail Partners 48 Ixis Asset Management 48 OTCBB CVBT 48 Protalex Inc. 48 Group Inc JEF.N 48 IDEC Pharmaceuticals 48 VasoGenix Pharmaceuticals 48 Sunesis Pharmaceuticals Inc. 48 ImmunoCellular 48 Nasdaq STAA 48 SKBI 48 NASDAQ LGND 48 Newlight Associates 48 PDL Biopharma 48 EntreMed Inc. 48 Nanophase Technologies 48 Laminar Direct Capital 48 Evaluate Strategic Alternatives 48 CDC IXIS Asset Management 48 PROFILE CO 48 Initiates Quarterly Dividend 48 Ciphergen Biosystems 48 Shareholders Approve Sale 48 Inc. Nasdaq IMGN 48 Stockholders Approve Merger Agreement 48 KAI Pharmaceuticals Inc. 48 ARCA Biopharma 48 Enzon Pharmaceuticals Inc 48 NRDC Acquisition Corp. 48 TargeGen 48 JPMP 48 analyst Edward Sterck 48 PTV Sciences 48 Lowers Estimates 48 Dr. Jim Birchenough 48 Spine Wave 48 Chemokine Therapeutics 48 AgeChem Venture Fund 48 Sagent Advisors Inc. 48 GNLB 48 Jonathan Aschoff 48 Capmark VII 48 Altus Pharmaceuticals Inc. 48 Successfully Completes Acquisition 48 Inc. NASDAQ BPSG 48 NASDAQ QCOR 48 EPIX Pharmaceuticals Inc. 48 IVAX Pharmaceuticals 48 Dividend Yield Outperforms 48 Announce Definitive Agreement 48 Novus Ventures 48 = CONTACT [001] 48 Mark Schoenebaum 48 MacroMed 48 Botanical Laboratories 48 CPA CFP 48 LEXINGTON Mass. Cubist Pharmaceuticals 48 firm GTCR Golder 48 Xoma Ltd. XOMA 48 Electro Optical Sciences 48 Ambit Biosciences 48 Equity Partners LP 48 ICOS Corporation 48 PRNewswire FirstCall Amylin Pharmaceuticals 48 JMP Securities LLC 48 Nasdaq NRGN 48 Nextech Venture 48 Claymore Equal Weight 48 Ventures Flagship Ventures 48 analyst Lawrence Keusch 48 Shares Popped What 48 NovaBay Pharmaceuticals 48 Inc.Media 48 Melior Discovery 47 VANGUARD NATURAL RESOURCES 47 NASDAQ APPA 47 Inc. Nasdaq GXDX 47 Wealth Advisers 47 Ambrish Srivastava 47 NASDAQ PRCS 47 Cassidy Turley represented 47 representing upland cotton 47 Movers Roundup 47 BTRX 47 NephRx 47 Diffusion Pharmaceuticals 47 NASDAQ DRRX 47 NASDAQ ALTH 47 Ben Mogil 47 Bullish Engulfing Formed 47 Healthcare Tailwinds Conference 47 Signs Definitive Merger Agreement 47 Esperion Therapeutics Inc. 47 Oxigene 47 Barclays Capital Reiterate Overweight 47 Xenoport Inc. 47 AMEX AOM 47 Aderis Pharmaceuticals 47 FOXH 47 Insys Therapeutics 47 NASDAQ OSIP announced 47 Corporation NasdaqGS 47 Upcoming Presentation 47 Transave 47 Procopio Cory Hargreaves 47 TKPHF 47 Gryphon Investors 47 NYSE MRX 47 Fogler Rubinoff LLP 47 RedPath Integrated Pathology 47 Terrex Energy 47 NASDAQ ARRY 47 Nasdaq FURX 47 TPPH 47 analyst Amit Hazan 47 Inc. OTCBB CAXG 47 Connetics Corporation 47 Inc. Attracting Bullish 47 Arete Therapeutics 47 Sonus Pharmaceuticals 47 FPA Perennial Fund 47 Inc.Investor 47 Aisling Capital 47 GuardID Systems 47 -0 CONTACT 47 Techulon 47 SeraCare Life Sciences 47 www.endocare.com 47 Altaris Capital Partners 47 Anadys Pharmaceuticals 47 analyst Randall Stanicky 47 MetaMorphix Inc. 47 Beats Estimates Analyst Blog 47 OTCBB IOPM 47 BioMarker Strategies 47 Lead Bookrunning Manager 47 WFG Capital 47 NasdaqGM ADLR today 47 www.barriertherapeutics.com 47 Acuity Pharmaceuticals 47 AlgoRx Pharmaceuticals Inc. 47 NASDAQ ZIOP 47 Curagen 47 NASDAQ ONXX 47 Bioform Medical 47 Hainan Helpson Medical 47 visit http:/www.PAREXEL.com 47 Neuroptix 47 Bioanalytical Systems Inc. 47 Tethys Bioscience 47 Genworth Financial Wealth Management 47 China Aoxing Pharmaceutical 47 Ventures MPM Capital 47 Metabasis Therapeutics Inc. 47 Capstone Investments 47 Ilypsa 47 M.D. Joins 47 Retains Investor Relations 47 SSRX 47 AmpliMed 47 ORIX Capital Markets 47 PRN Oncolytics Biotech 47 Closed End Funds Declare 47 NASDAQ ARIA 47 Aeris Therapeutics 47 OTCBB CHKT biotechnology 47 Keay Nakae 47 Westwind Partners Inc. 47 Guilford Pharmaceuticals 47 SmithBarney 47 Inc.Investor Relations 47 Northwater Capital Management 47 #Director Investor Relations 47 MOGN 47 Infinity Pharmaceuticals 47 Dave Bonaccorso 47 Nasdaq PDLI 47 NASDAQ KOSN 47 CytoDyn Inc. 47 Inc. Nasdaq AVII 47 Yaron Werber 47 Hyperion Therapeutics 47 Jefferies Quarterdeck division 47 Merriman Curhan 47 Ardea Biosciences 47 ALung Technologies 47 Abbot Labs 47 LF Rothschild Unterberg 47 Holds Annual Meeting 47 Akhtar Samad 47 Aberdare Ventures 47 Adenosine Therapeutics LLC 47 Wrightwood Capital 47 Jiangbo Pharmaceuticals 47 Genelabs Technologies Inc. 47 Xoma Ltd 47 Savvian 47 Gendux AB 47 Durect Corp. 47 Myrexis Inc. 47 NASDAQ PANC 47 Inc. Nasdaq MERR 47 Thoratec Presentation 47 Paul Adornato 47 website www.lipidsciences.com 47 Cbiz 47 Creabilis Therapeutics 47 PRN CORRECTION 47 Spaltudaq 47 Adolor Corporation 47 DLA Piper LLP 47 Inc. Nasdaq NSTK 47 OTC BB PVCT 47 NASDAQ ENZN 47 About Exelixis Exelixis 47 Balyasny Asset Management 47 Pluristem Therapeutics 47 NASDAQ EPIX 47 Nasdaq ACHN 47 Interventional Systems 47 Entropin 47 Inc.Robert 47 Finalizes Sale 47 AMEX ANX 47 PRNewswire FirstCall Palatin Technologies 47 Ventures InterWest Partners 47 Inc. NASDAQ MRNA 47 Stays Neutral 47 Lorus Therapeutics 47 Chuck Dohrenwend 47 Threshold Pharmaceuticals Inc. 47 BANKING SOURCE 47 LifeSpan BioSciences 46 MBRX 46 Regado Biosciences 46 Penwest Pharmaceuticals 46 -RL Lipton 46 AtheroNova 46 Nasdaq PSTI 46 please visit www.medicinova.com 46 Cypress Bioscience Inc 46 CyberTrader R 46 AcelRx Pharmaceuticals 46 Headwaters MB 46 Firmani + Associates 46 advisery firm 46 Seligman Advisors 46 PRNewswire FirstCall Corgentech 46 Epiphany Biosciences 46 NASDAQ EXAS 46 RedChip Visibility division 46 Ventrus Biosciences 46 Limited Dealings 46 Corporation NASDAQ PRXL 46 Martek Bioscience 46 Commences Tender Offer 46 Ilex Oncology Inc. 46 ARCA biopharma Inc. 46 MacroPore Biosurgery 46 Lixte Biotechnology Holdings 46 ALZA Corporation 46 Prides Capital 46 Oncolin Therapeutics Inc. 46 Reschedules Fourth Quarter 46 JM Dutton 46 Anthera Pharmaceuticals 46 Founding Shareholder 46 NasdaqCM PSTI DAX PJT 46 Renews Expands 46 ECTE 46 Parters 46 Revivicor 46 Completes Spin Off 46 CIMA LABS 46 Releases Third Quarter 46 Andrx Corporation 46 Argonaut Ventures 46 Finalizes Acquisition 46 Putnam Lovell NBF 46 RDEA 46 OTCBB PVCT 46 Avila Therapeutics 46 Stifel Nicholaus 46 OptionsXpress Holdings 46 QuestMark Partners 46 RiverFront Investment Group 46 Inc. Nasdaq SUPG 46 NYSE Amex PBTH 46 OPKO Health 46 Freeman Spogli 46 WR Hambrecht + 46 http:/www.parpharm.com 46 OTCBB PYTO 46 ISTA Pharmaceuticals 46 Flexpoint Ford 46 Nasdaq INHX 46 Bioservices 46 Candlesticks Bearish Engulfing 46 iVOW 46 analyst Tore Svanberg 46 ReVision Optics 46 Inc NGSX 46 Nasdaq CBST 46 Medicis Pharmaceuticals 46 Tenthoff 46 Titan Pharmaceuticals 46 Parnters 46 Andromeda Biotech 46 Strategem Capital Corporation 46 MBX TSX 46 Nventa Biopharmaceuticals 46 #,#,# #,#,# Noncontrolling interests [001] 46 IntraBiotics Pharmaceuticals Inc. 46 Roche OTC RHHBY 46 Amex KAL 46 PRNewswire FirstCall Onyx Pharmaceuticals 46 Littlebanc Advisors LLC 46 OTCBB ILNS 46 ValueAct Capital Partners LP 46 NASD Fines 46 Adeona Pharmaceuticals Inc. 46 please visit www.lazard.com 46 Inc. NASDAQ HGSI 46 EarlyBirdCapital Inc. 46 Occulogix 46 Reversal Soon 46 About Chemokine Therapeutics 46 Nasdaq ABIO biopharmaceutical 46 Ception Therapeutics 46 Jefferies Quarterdeck 46 OTCBB EMIS 46 CypressTree Investment Management 46 NASDAQ CBST today 46 Genitope Corporation 46 Renhuang Pharmaceuticals 46 ImmunoCellular Therapeutics Ltd. 46 Nasdaq SIVB 46 Grandich Publications LLC 46 Perlegen Sciences Inc. 46 BioMimetic Therapeutics NASDAQ BMTI 46 Nasdaq VTIV 46 RegeneRx Biopharmaceuticals Inc. 46 AgeChem 46 DRRX 46 Partners NVP 46 Sucampo Pharma Americas 46 GeneOhm Sciences 46 RNK Capital 46 Allergan NYSE AGN 46 OXIS International 46 McMorgan 46 Abnova 46 Reiterates Buy 46 NASDAQ IDEV 46 NASDAQ IMGN 46 Luther King Capital 46 Resigns Quick Facts 46 Upcoming Investor Conference 46 Nasdaq DRRX 46 Cortec Group 46 Dynavax Technologies Corporation 46 Nucryst Pharmaceuticals Corp. 46 Nasdaq MICU 46 Ardais 46 Q1 Adj 46 Actelion Pharmaceuticals 46 Nasdaq MBRX 46 Primus Pharmaceuticals 46 TSRX 46 TSX FSE HBP 46 DeNovo Ventures 46 SciClone Pharmaceuticals 46 Jason Kolbert 46 AmpliMed Corporation 46 Quarterdeck Investment 46 PRNewswire FirstCall Sunesis Pharmaceuticals 46 Brian Bapty 46 Dimensional Pharmaceuticals 46 www.vivus.com 46 ProMetic BioSciences 46 DLJ Merchant 46 Rustic Canyon Ventures 46 InVivo Therapeutics Corporation 46 NASDAQ BMTI 46 Axelrod Weinberger Associates 46 Northstar Neuroscience Inc. 46 Knopp Neurosciences 46 Ambrian Partners Limited 46 ComVest Investment Partners 46 Lawrence Keusch 46 Apricus Biosciences 46 Birchmere Ventures 46 Announces Earnings Release 46 Inc.John 46 Cooley Godward Kronish LLP 46 reinitiates coverage 46 Charlesbank Capital Partners 46 Achillion Pharmaceuticals Inc. 46 SomaLogic 46 Ardour Capital Investments 46 MPM BioEquities 46 Accera Inc. 46 Convergent Wealth Advisors 46 Corroon LLP 46 Nasdaq VRTX 46 developing chemokine 46 AlphaPro Management 46 NASDAQ AVEO 46 Marquest Asset Management 46 analyst Patrick Walravens 46 AMVAC Chemical 46 chiefexecutive officer 46 Cyclacel Pharmaceuticals 46 Engages Investor Relations 46 #Chief Executive 46 OMRIX Biopharmaceuticals Inc. 46 Conference Call TRANSCRIPT 46 Geron NASDAQ GERN 46 Cellgate Inc. 46 NASDAQ NRGN 46 LabNow 46 Kaye Scholer LLP 46 Urigen Pharmaceuticals Inc.